![]() |
市場調查報告書
商品編碼
1883025
醫療旅遊市場規模、佔有率、成長及全球產業分析:按類型、應用和地區劃分的洞察與預測(2024-2032)Medical Treatment Tourism Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
隨著越來越多的病患跨國尋求經濟高效、高品質的醫療服務,全球醫療旅遊市場正經歷快速擴張。根據2024年的產業評估,預計2024年全球市場規模將達到172.3億美元,2025年將成長至210.9億美元,並最終在2032年達到驚人的912.7億美元。這意味著2025年至2032年的複合年增長率高達23.3%。 2024年,北美以35.69%的市佔率引領全球市場,主要得益於大量國際患者的湧入和強勁的跨國醫療需求。
醫療旅遊是指前往國外接受醫療服務,例如心臟護理、牙科手術、腫瘤治療和骨科手術,主要目的是降低費用和縮短等待時間。全球醫療旅遊的蓬勃發展得益於醫療基礎設施的不斷改進、發展中國家治療的成本效益以及先進技術的普及。
例如,2025年5月,SPARSH醫院集團在印度班加羅爾開設了一家擁有300張床位的四級醫療機構,配備了機器人手術系統、人工智慧診斷、即時分析和先進的行動通訊技術。此類投資顯著提升了新興市場的醫療能力,並鼓勵更多國際患者出國就醫。
市場動態
市場驅動因素
癌症、心臟病和骨科疾病等慢性病的日益普及是推動醫療旅遊發展的最重要因素之一。已開發國家漫長的等待時間和高昂的醫療費用促使患者尋求在國外進行快速且經濟的手術。例如,由於土耳其的醫療費用低於歐洲和美國,預計2023年將有150萬名患者前往土耳其接受治療,其中超過40%的患者來自歐洲。
此外,國際認證,例如國際聯合委員會(JCI)的認證,正在增強病患的信心。策略性擴張,例如RivExcel和美國杜拜醫院於2024年在拉各斯開設醫療旅遊辦事處,正在改善醫療服務的可近性,並吸引更多國際患者。
市場限制因子
術後併發症和追蹤護理不足仍然是主要的限制因素。許多患者在手術後立即回家,限制了他們獲得術後護理的機會。這增加了感染、傷口癒合延遲和深部靜脈栓塞(DVT)等併發症的風險。例如,許多前往國外接受減重手術的英國患者報告稱,由於缺乏協調的後續護理,出現了嚴重的併發症。
此外,缺乏標準化的復健方案以及國際醫療標準的差異,也使得一些患者無法選擇海外治療。
市場機會
政府主導的努力對於促進醫療旅遊至關重要。各國都在積極進行宣傳活動並建立戰略夥伴關係,以加強其在該領域的國際影響力。例如,杜拜衛生局 (DHA) 參加了吸引了來自 150 多個國家參與者的第 30 屆阿拉伯旅遊市場,這表明其致力於將杜拜打造成為全球醫療旅遊中心。此外,阿聯酋經濟部與杜拜衛生局於 2022 年簽署的諒解備忘錄 (MoU) 等協議,進一步加強了雙方在促進醫療旅遊方面的合作。
市場挑戰
倫理問題和有限的保險覆蓋範圍仍然是挑戰。巴基斯坦和埃及等國因不道德的器官移植行為而受到審查,影響了全球信任。保險限制增加了經濟風險,因為大多數國際手術都不在保險範圍內。例如,在美國接受手術的土耳其患者通常必須自費支付全部費用。
市場趨勢
對經濟實惠的治療目的地的偏好日益增強
土耳其、墨西哥、泰國、韓國和印度等國家正成為提供經濟實惠、高品質醫療服務的首選之地。例如,在土耳其進行心臟搭橋手術的費用在7000美元到15000美元之間,而在美國則超過70000美元,這意味著顯著的費用節省。
機器人手術系統的引進
機器人輔助手術(RAS)因其更高的精準度和更快的恢復速度而備受國際患者的青睞。亞太地區、歐洲和中東地區對機器人系統的日益普及正在推動醫療旅遊業的發展。
區域分析
歐洲
2024年,歐洲市場以61.5億美元的規模領先全球市場。高標準的醫療水平、先進的醫療設施以及諸如居里研究所聖克盧醫院等新建醫院,都鞏固了該地區的領先地位。
北美
2024年,北美佔了第二大市場。政府主導的醫療旅遊計劃,例如2022年美韓合作項目,進一步增強了該地區的發展勢頭。
亞太地區
預計到2032年,亞太地區將以最高的複合年增長率成長。印度的 "印度醫療計畫" (Heal in India)等政府計畫吸引了許多國際患者。
拉丁美洲、中東和非洲
隨著新的醫療旅遊機構的建立和臨床基礎設施的擴建,預計這些地區將經歷穩定成長。
The global medical treatment tourism market is experiencing rapid expansion as patients increasingly travel across borders to access cost-effective, high-quality healthcare services. According to the 2024 industry assessment, the global market was valued at USD 17.23 billion in 2024 and is set to rise to USD 21.09 billion in 2025, ultimately reaching an impressive USD 91.27 billion by 2032. This reflects a strong CAGR of 23.3% during 2025-2032. In 2024, North America led the global market with a 35.69% share, driven by high outbound patient flow and strong cross-border healthcare demand.
Medical treatment tourism involves traveling abroad for medical procedures-such as cardiac care, dental surgery, oncology treatments, and orthopedic procedures-primarily for cost savings and reduced waiting times. The global boom is supported by expanding healthcare infrastructure, affordability of treatments in developing nations, and improved access to advanced technologies.
For example, in May 2025, SPARSH Group of Hospitals opened a new 300-bed quaternary care facility in Bangalore, India, equipped with robotic surgery systems, AI-based diagnostics, real-time analytics, and advanced cellular technologies. Such investments significantly elevate medical capabilities in emerging markets, encouraging more international patients to seek treatment abroad.
Market Dynamics
Market Drivers
Rising chronic disease prevalence-such as cancer, cardiac disorders, and orthopedic diseases-is one of the strongest drivers of medical travel. Long waiting periods and high healthcare costs in developed nations prompt patients to seek quicker and more economical surgeries abroad. For example, 1.5 million patients visited Turkey in 2023 for medical treatments due to lower costs compared to Europe and the U.S., with more than 40% of travelers arriving from Europe.
Additionally, international accreditations like Joint Commission International (JCI) are boosting trust among patients. Growing strategic expansions-such as RivExcel and American Hospital Dubai launching medical tourism offices in Lagos in 2024-support international patient inflow by improving access to care.
Market Restraints
Post-operative complications and inadequate follow-up care remain major limitations. Many patients return home shortly after surgery, limiting access to post-treatment care. This creates risks such as infections, delayed healing, and complications like Deep Vein Thrombosis (DVT). For example, many U.K. patients traveling abroad for obesity surgeries reported serious complications due to lack of coordinated follow-up care.
Moreover, the absence of standardized recovery protocols and variable international healthcare standards discourage some patients from choosing overseas treatments.
Market Opportunities
Government initiatives have become crucial in promoting medical tourism. Countries are actively launching campaigns and forming strategic alliances to strengthen their global presence in the healthcare tourism sector. For instance, Dubai Health Authority's participation in the 30th Arabian Travel Market with attendees from over 150 nations demonstrated its commitment to positioning Dubai as a global health tourism hub. In addition, MoUs-such as the 2022 agreement between UAE's Ministry of Economy and DHA-enhance cooperation for medical tourism promotion.
Market Challenges
Ethical concerns and limited insurance coverage continue to pose challenges. Countries like Pakistan and Egypt have faced scrutiny for unethical organ transplant practices, affecting global trust. Insurance limitations add financial risk, as most international procedures are not covered; for example, a U.S. patient undergoing surgery in Turkey must typically pay entirely out of pocket.
Market Trends
Growing Preference for Affordable Treatment Destinations
Countries such as Turkey, Mexico, Thailand, South Korea, and India have emerged as top choices for affordable and high-quality care. For example, heart bypass surgery costs between USD 7,000-15,000 in Turkey, compared to more than USD 70,000 in the U.S., highlighting substantial cost savings.
Adoption of Robotic Surgery Systems
Robotic-assisted surgeries (RAS) offer higher precision and quicker recovery, making them attractive for international patients. The growing availability of robotic systems in Asia Pacific, Europe, and the Middle East is accelerating medical tourism.
Regional Analysis
Europe
Europe dominated the market in 2024, reaching USD 6.15 billion. Strong healthcare quality, advanced medical facilities, and new hospitals-such as Institut Curie's Saint-Cloud facility in France-support regional leadership.
North America
North America held the second-largest share in 2024. Government-led medical travel initiatives, such as U.S.-Korea collaborations in 2022, continue to strengthen regional momentum.
Asia Pacific
Asia Pacific is projected to grow at the highest CAGR through 2032. Government programs such as India's "Heal in India" initiative are attracting significant numbers of international patients.
Latin America & Middle East-Africa
These regions are seeing steady growth driven by new medical tourism offices and expanding clinical infrastructure.
Conclusion
With the global market increasing from USD 17.23 billion in 2024 to USD 91.27 billion by 2032, medical treatment tourism is set for remarkable expansion. Growing affordability, stronger healthcare ecosystems, and government-backed initiatives are reshaping global patient mobility and transforming the future of cross-border healthcare.
Segmentation
By Service Type
By Age Group
By Service Provider
By Region